Lawrence E. Broder
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 12
- Lung Cancer Research Studies 9
- Pancreatic and Hepatic Oncology Research 2
- Epidemiology 10
- Neuroendocrine Tumor Research Advances 9
- Co-authors
- Martin H. Cohen (9 shared papers)Oleg S. Selawry (4 shared papers)Thomas H. Maren (2 shared papers)Stephen K. Carter (2 shared papers)Byron E. Fossieck (3 shared papers)John D. Minna (5 shared papers)Frank M. Schabel (1 shared paper)Thomas P. Johnston (1 shared paper)
- Journals
- Cancer (3 papers)Annals of Internal Medicine (2 papers)Cancer Treatment Reviews (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Cancer Letters (1 paper)
- Partner nations
- United StatesUkrainePoland
In The Last Decade
Lawrence E. Broder
28 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Oncology 675
- Epidemiology 549
- Neurology 197
- Pulmonary and Respiratory Medicine 181
- Cancer Research 71
Countries citing papers authored by Lawrence E. Broder
This map shows the geographic impact of Lawrence E. Broder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence E. Broder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence E. Broder more than expected).
Fields of papers citing papers by Lawrence E. Broder
This network shows the impact of papers produced by Lawrence E. Broder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence E. Broder. The network helps show where Lawrence E. Broder may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence E. Broder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1973 | 253 | |
| 2 | Intensive chemotherapy of small cell bronchogenic carcinoma. | 1977 | 212 |
| 3 | 1973 | 143 | |
| 4 | 1973 | 103 | |
| 5 | 1977 | 88 | |
| 6 | 1974 | 60 | |
| 7 | 1968 | 56 | |
| 8 | Experimental studies of the biology of human small cell lung cancer. | 1983 | 52 |
| 9 | Cisplatin-induced autonomic neuropathy. | 1984 | 45 |
| 10 | 1970 | 41 | |
| 11 | Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma. | 1977 | 40 |
| 12 | 1979 | 39 | |
| 13 | 1977 | 17 | |
| 14 | 1978 | 15 | |
| 15 | Combination chemotherapy with vincristine, adriamycin, and procarbazine in previously treated patients with small cell carcinoma. | 1977 | 14 |
| 16 | 1981 | 13 | |
| 17 | 1973 | 12 | |
| 18 | 1994 | 8 | |
| 19 | 1984 | 8 | |
| 20 | 1976 | 6 |
About Lawrence E. Broder
Lawrence E. Broder is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (9 papers), Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Treatments and Mutations (4 papers), Amino Acid Enzymes and Metabolism (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Electrolyte and hormonal disorders (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (675 citations), Epidemiology (549 citations), Neurology (197 citations), Pulmonary and Respiratory Medicine (181 citations) and Cancer Research (71 citations). Lawrence E. Broder has collaborated with scholars based in United States, Ukraine and Poland. Frequent co-authors include Martin H. Cohen, Oleg S. Selawry, Thomas H. Maren, Stephen K. Carter, Byron E. Fossieck, John D. Minna, Frank M. Schabel, Thomas P. Johnston, Douglass C. Tormey and Patrick J. Creaven. Their work appears in journals such as Cancer, Annals of Internal Medicine, Cancer Treatment Reviews, Journal of Pharmacology and Experimental Therapeutics and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.